Hemothorax pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing.
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing.
==Overview==
==Overview==
Haemothorax is a pathologic collection of blood within the [[pleural cavity]], between the [[lung]] surface and inner [[Thoracic cavity|chest wall]]. Three mechanisms of bleeding in haemothorax include torn adhesion between the [[Pleural cavity|parietal and visceral pleurae]], rupture of neovascularized bullae as a complication of subpleural emphysematous blebs, and torn [[congenital]] aberrant vessels branching from the cupola and distributed in and around the bulla in the apex of the lung. There are some genetic disorder that are predisposed to haemothorax.


==Pathophysiology==
==Pathophysiology==

Revision as of 07:47, 16 March 2018

Hemothorax Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemothorax from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography or Ultrasound

CT

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemothorax pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemothorax pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemothorax pathophysiology

CDC on Hemothorax pathophysiology

Hemothorax pathophysiology in the news

Blogs on Hemothorax pathophysiology

Directions to Hospitals Treating Hemothorax

Risk calculators and risk factors for Hemothorax pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Haemothorax is a pathologic collection of blood within the pleural cavity, between the lung surface and inner chest wall. Three mechanisms of bleeding in haemothorax include torn adhesion between the parietal and visceral pleurae, rupture of neovascularized bullae as a complication of subpleural emphysematous blebs, and torn congenital aberrant vessels branching from the cupola and distributed in and around the bulla in the apex of the lung. There are some genetic disorder that are predisposed to haemothorax.

Pathophysiology

Pathogenesis

Three mechanisms of bleeding in haemothorax:

  • Torn adhesion between the parietal and visceral pleurae.
  • Rupture of neovascularized bullae as a complication of subpleural emphysematous blebs.
  • Torn congenital aberrant vessels branching from the cupola and distributed in and around the bulla in the apex of the lung.

Genetics

  • Hemophilia A is a X-linked hereditary disorder of blood clotting that caused by the development of an inhibitor against coagulation factor VIII (FVIII). Hemophilia A manifests with early muscle and subcutaneous bleeding and rarely with haemothorax.

References

Template:WH Template:WS